Generics

Press enter to search
Close search
Open Menu

Generics

News and information on generic drugs sold in retail pharmacies, as well as their suppliers.

Generic pill bottles.

Dr. Reddy's debuts Tecfidera generic

The Tecfidera brand and generic had a market value of roughly $3.8 billion for the most recent 12 months ended June 2020, according to IQVIA.

A pink and blue pill with money inside.

AAM report: Generic savings totaled $313B in 2019

The U.S. healthcare system saved $313 billion in 2019 due to low-cost generics, according to a new report by the Association for Accessible Medicines.

Taro Pharmaceutical is introducing its first specialty generic, a therapeutic equivalent to Ferriprox.

For the year ended July 2020, IQVIA data showed U.S. sales of roughly $3.8 billion for Tecfidera.

Injectable vials.

Brand and generic sales for Precedex in 0.9% sodium chloride injection were $210 million for the most recent 12 months ended June 2020, according to IQVIA.

White pill bottle against a blue background.

Salix will maintain market exclusivity for Xifaxan (rifaximin) 200 mg and 550 mg tablets until 2028.

Camber's generic Tecfidera provides a treatment for relapsing forms of multiple sclerosis.

Pharmacy shelves with various medications.

Hikma said it now expects to receive FDA approval for its generic Advair Diskus in early 2021.

A hand holding a generic pill bottle.

Divalproex sodium ER tablets had a market value of approximately $130 million, according to IQVIA July 2020 data.

A man holding an FDA approved sign.

Zydus Cadila’s generic K-Dur will be available in dosage strengths of 750 mg and 1,500 mg.

A hand holding a prescription box.

Tripoint will commercialize SPARC's Elepsia XR tablets for five years, with the option to extend the agreement further.

Generic pill bottles.

Dr. Reddy's will be able to sell volume-limited amounts of generic lenalidomide capsules after March 2022, and an unlimited volume beginning Jan. 31, 2026.

Injectable vials.

Liposomal doxorubicin injection had a market value of approximately $124 million for the 12 months ended July 2020, according to IQVIA.

A man holding an FDA approved sign.

Prednisone tablets have a market value of roughly $12 million, according to IQVIA July 2020 data.

Show More